Cibus (CBUS) Cyclically Adjusted Revenue per Share: $10.32 (As of Mar. 2026)


CBUS Cibus Inc CBUS
54 GF Score
Price $1.39
GF Value $2.04
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cibus Cyclically Adjusted Revenue per Share?

Cibus CBUS -1.42% 54 Cyclically Adjusted Revenue per Share is $10.32 as of Mar. 2026. GuruFocus rates CBUS with a GF Score™ of 54/100 and a GF Value™ of $2.04 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cibus's adjusted revenue per share for the three months ended in Mar. 2026 was $0.026. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $10.32 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-05), Cibus's current stock price is $1.385. Cibus's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $10.32. Cibus's Cyclically Adjusted PS Ratio of today is 0.13.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Cibus was 0.37. The lowest was 0.12. And the median was 0.15.


Cibus  (NAS:CBUS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cibus's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.385/10.32
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Cibus was 0.37. The lowest was 0.12. And the median was 0.15.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cibus Cyclically Adjusted Revenue per Share Related Terms


Cibus Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cibus's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cibus Cyclically Adjusted Revenue per Share Chart

Cibus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 10.15

Cibus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 10.44 10.15 10.32

CBUS vs VANI, KLRS, AARD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Cibus's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cibus Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cibus's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cibus's Cyclically Adjusted PS Ratio falls into.


CBUS
54GF Score
Cibus Inc CBUS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cibus Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cibus's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.026/330.2130*330.2130
=0.026

Current CPI (Mar. 2026) = 330.2130.

Cibus Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.218 241.018 0.299
201609 0.197 241.428 0.269
201612 0.135 241.432 0.185
201703 0.103 243.801 0.140
201706 0.435 244.955 0.586
201709 0.086 246.819 0.115
201712 0.335 246.524 0.449
201803 0.020 249.554 0.026
201806 0.328 251.989 0.430
201809 0.042 252.439 0.055
201812 0.003 251.233 0.004
201903 0.240 254.202 0.312
201906 0.623 256.143 0.803
201909 4.516 256.759 5.808
201912 5.710 256.974 7.337
202003 3.602 258.115 4.608
202006 3.490 257.797 4.470
202009 7.893 260.280 10.014
202012 19.182 260.474 24.318
202103 5.925 264.877 7.386
202106 15.968 271.696 19.407
202109 10.405 274.310 12.525
202112 2.537 278.802 3.005
202203 0.038 287.504 0.044
202206 0.044 296.311 0.049
202209 0.045 296.808 0.050
202212 0.043 296.797 0.048
202303 0.043 301.836 0.047
202306 0.032 305.109 0.035
202309 0.029 307.789 0.031
202312 0.054 306.746 0.058
202403 0.026 312.332 0.027
202406 0.038 314.175 0.040
202409 0.071 315.301 0.074
202412 0.046 315.605 0.048
202503 0.029 319.799 0.030
202506 0.022 322.561 0.023
202509 0.012 324.800 0.012
202512 0.020 324.054 0.020
202603 0.026 330.213 0.026

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $10.32 mean?
Cibus (CBUS) has a Cyclically Adjusted Revenue per Share of $10.32 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cibus and its competitors.
Is Cibus' Cyclically Adjusted Revenue per Share too high?
Cibus' current Cyclically Adjusted Revenue per Share is $10.32. Overall, Cibus has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cibus' Cyclically Adjusted Revenue per Share compare to VANI and KLRS?
Cibus' Cyclically Adjusted Revenue per Share of $10.32 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cibus and its competitors. Cibus's current Cyclically Adjusted Revenue per Share is $10.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cibus stock overvalued right now?
Based on GuruFocus' analysis, Cibus (CBUS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.04, compared to a current price of $1.39 — trading 32.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $10.32. Cibus' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cibus (CBUS), the current Cyclically Adjusted Revenue per Share is $10.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cibus (CBUS) Overvalued in 2026?

Based on GuruFocus' analysis, Cibus stock appears to be undervalued. The current stock price of $1.39 is trading 32.1% below its estimated GF Value™ of $2.04. GuruFocus considers Cibus to be Possible Value Trap.

Key valuation signals for CBUS:

  • Cyclically Adjusted Revenue per Share: $10.32
  • GF Value™: $2.04 vs. price of $1.39 (32.1% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the CBUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cibus Business Description

Address 6455 Nancy Ridge Drive, San Diego, CA, USA, 92121
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
54GF Score

Get the complete analysis for CBUS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.39
Price
$2.04
GF Value